- ROYLENE GALBRAITH
- GILLIAN SCHROEDER
This weekly case conference is designed to review and discuss breast cancer diagnoses, individual patient cases, and care plans. It is intended for the multidisciplinary team, which includes breast surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, genetic counselors, APPs, nurses, fellows, residents, and research staff.
- Nurse Practitioners
- Physician Assistants
- Social Workers
|Lee Wilke, Chair||Roylene Galbraith||Gillian Schroeder|
|Stacey Johnson||Jane Jachowicz|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .01 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
Upon completion of this activity participants will have gained insight into the clinical practice of other disciplines and specialties caring for breast patients and apply that learning by contributing to the discussion and development of improved and standardized processes for patient treatment.